Clinical Trial Update: Tranylcypromine Treatment of Bipolar Depression [Phase 4]

View source ↗

Summary

Phase 4 study of tranylcypromine for bipolar depression has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder

Drugs mentioned

• Parnate (tranylcypromine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Bipolar Disorder I or II | Phase 4 | Status: COMPLETED | Results posted: 2018-03-15